U.S. Banks Stock News

In February 2026, Danaos Corporation reported earnings per share of 7.14 and revenue of US$266.26 million, both ahead of analyst expectations. The twin surprises in profit and sales highlight how Danaos’s containership fleet is currently converting charter demand into stronger-than-forecast financial results. With this earnings beat as a backdrop, we’ll now examine how stronger-than-expected profitability reshapes Danaos’s existing investment narrative. AI is about to change healthcare...

Investors may be wondering whether Capri Holdings shares still offer value after a turbulent few years, or if most of the opportunity is already reflected in the current price. The stock last closed at US$19.88, with returns of 10.7% over 7 days, 7.0% over 30 days, an 18.5% decline year to date and a 35.7% gain over the past year, while 3 and 5 year returns stand at 55.3% and 63.1% declines respectively. Recent price moves have come as investors reassess the brand portfolio and the broader...

Neogen has agreed to sell its Genomics business to Zoetis as part of a wider portfolio reshaping. The company has completed the divestiture of its Cleaners and Disinfectants business. Neogen is implementing a major restructuring, including a 10% global headcount reduction. These actions concentrate the business around its core Food Safety segment and streamline operations. For investors watching NasdaqGS:NEOG, these moves come after a mixed share price history. The stock is at $9.42, with a...

If you are wondering whether Jazz Pharmaceuticals at around US$194.20 is still offering value after a strong run, the key is to look closely at what the current price actually reflects. The stock has posted returns of 3.9% over the last 7 days, 8.8% over 30 days, 12.2% year to date, and 93.2% over the past year, which naturally raises questions about how much of the story is already priced in and how risk is being perceived. Recent attention on Jazz Pharmaceuticals has centered on its...

If you are wondering whether Futu Holdings at US$154.50 is still reasonably priced after a strong run, the next sections will focus squarely on what the current share price might imply about value. The stock has returned 10.2% over the past week and 9.5% over the past month, with a 92.2% return over the last year but a 13.4% decline year to date and a 230.6% return over three years and 3.3% over five years. Recent coverage has highlighted Futu Holdings as a prominent online brokerage play...

Medpace Holdings (NasdaqGS:MEDP) is facing multiple shareholder class action lawsuits tied to alleged false and misleading statements about its book to bill ratio and backlog cancellation rates. Investors claim they suffered losses after company disclosures, with recent insider stock sales by the CEO shortly before negative updates adding to concerns. The litigation focuses on whether management provided overly optimistic projections that did not align with internal business conditions. For...

Freshworks (NasdaqGS:FRSH) appointed Kuntal Vahalia as Senior Vice President, Partnership Channel. Vahalia will lead the company’s global partner strategy with a focus on the partner channel. The role includes supporting Freshworks’ efforts to move further upmarket and deepen ties with global system integrators. For investors tracking SaaS platforms, Freshworks operates in the customer and employee experience software space, where partner ecosystems often influence how quickly products...

Five Below (NasdaqGS:FIVE) reported strong quarterly results, with revenue and earnings exceeding analyst expectations. The company opened a new store in Corbin, Kentucky, adding to its growing brick and mortar footprint. Management, led by CEO Winnie Park, highlighted ongoing progress on key business initiatives alongside the latest store launch. Five Below enters this update cycle with its shares at $217.37 and a very large 1 year return of 259.5%. The company has also recorded a 12.4%...

If you are wondering whether Winmark at around US$444 per share offers good value or if you might be arriving late, this piece lays out the key facts so you can judge the price for yourself. The stock has recently moved 3.2% over the last 7 days, with a 1 year return of 37.5% and 10.6% year to date. The 30 day return sits at a 1.2% decline and the 3 and 5 year returns are 46.1% and 163.2% respectively. Recent attention around Winmark has focused on its position in the Specialty Retail space...

If you are wondering whether Ventas at around US$84.96 is offering fair value or a stretched price, you are in the right place for a clear valuation breakdown. The stock has returned 2.0% over the last week, 9.9% year to date and 32.0% over the past year. Over the last 30 days it has declined 1.8%, which may have shifted some investors' sense of risk and opportunity. Recent coverage has focused on Ventas in the context of its role as a health care focused REIT, with attention on how its...

Anbio Biotechnology, NasdaqGM:NNNN, is expanding beyond COVID-19 diagnostics into a broader test portfolio. The company is rolling out new rapid immunoassay and PCR platforms across human health, veterinary, and multi-disease applications. This move reflects a business model shift toward more diversified diagnostic revenues and reduced reliance on legacy COVID-19 products. For you as an investor, this repositioning matters because Anbio Biotechnology is moving from a single product focus...

EQT (NYSE:EQT) agreed to purchase an additional 1 million metric tons of LNG per year from Commonwealth LNG, bringing its total contracted volume to 2 million tons annually. Glencore now has long-term commitments for 3 million tons of LNG per year from Commonwealth LNG. With these contracts, Commonwealth LNG reports that 8 of its planned 9.5 million tons of annual capacity is now under long-term agreements. EQT is a major U.S. natural gas producer, and this latest LNG deal increases its...

Wondering whether Perrigo's current share price makes sense or if the market has mispriced it? This article walks through the key valuation clues that can help you frame that question. The stock has seen a 0.1% move over the last 7 days and a 16.8% return over the past month, set against a much tougher picture with a 21.8% decline year to date and a 52.9% fall over the last year, as well as 65.7% and 68.3% declines over 3 and 5 years respectively. Recent attention on Perrigo has focused less...

ASP Isotopes (ASPI) has just put out its FY 2025 numbers, with Q4 revenue of about US$16.7 million and a Q4 basic EPS loss of US$0.76. Trailing twelve month revenue sits at roughly US$23.8 million against a TTM basic EPS loss of US$2.11. The company has seen quarterly revenue move from around US$1.2 million in Q4 FY 2024 to US$16.7 million in Q4 FY 2025, while trailing twelve month revenue shifted from about US$4.1 million to US$23.8 million over the same window. Investors will now be...

Unity Software (NYSE:U) is pivoting its ads business toward AI, positioning the Vector ad platform as its primary growth driver. The company is sunsetting the legacy ironSource Ads Network and is exploring a sale of its Supersonic publishing unit. Management expects Vector to reach a billion dollar annual run rate, with recent trends supporting upgrades to company guidance. Unity Software enters this shift with a share price of $21.62 and a mixed return profile, including a 51.1% decline...

State Street (NYSE:STT) has filed to launch a Nasdaq 100 Index ETF, entering a segment where Invesco has been a long-standing player. The firm is extending its relationship with Thornburg Investment Management to service new ETF share classes across Thornburg funds. Shareholders have introduced a proposal seeking a policy for an independent board chair at State Street. For investors watching the ETF space, these moves put State Street, a major global custody bank and asset manager, closer...

Adlai Nortye (NasdaqGM:ANL) has posted its FY 2025 first half results with total revenue of effectively US$0, a basic EPS loss of US$0.57 and net income loss of US$18.34 million, keeping the story firmly about cash burn and margins rather than top line scale. The company has seen recent periods marked by similarly low reported revenue, with basic EPS losses of US$0.64 and US$1.06 and net income losses of US$24.26 million and US$27.61 million across the two halves of FY 2024. As a result,...

In April 2026, Immunovant reported that two Phase 3 GO studies of its FcRn inhibitor batoclimab in adults with active, moderate-to-severe thyroid eye disease did not meet the pre-specified primary endpoint of ≥2mm proptosis response at Week 24, though safety findings remained consistent and no new signals emerged. The data suggested stronger proptosis improvements during the initial high-dose period and thyroid hormone normalization in hyperthyroid patients similar to prior Graves’ disease...

Medline (NasdaqGS:MDLN) has received an FDA warning letter citing manufacturing deficiencies in its angiographic syringe production. The letter, the first major regulatory challenge since Medline went public, focuses on quality and compliance issues with potential patient safety implications. The FDA action requires Medline to address identified problems and document corrective steps before the matter can be closed. For investors following Medline at a share price of $45.6, this FDA warning...

Jackson Financial (JXN) is in focus after the company reshaped its leadership by naming Christopher A. Raub as President and CEO of asset manager PPM America and adjusting roles at Jackson National Life Insurance Company. See our latest analysis for Jackson Financial. Recent leadership changes come as Jackson Financial’s share price has eased in the short term, with a 30 day share price return showing a 5.21% decline and a 90 day share price return showing a 13.41% decline. At the same time,...

Acuity Inc. recently reported past second-quarter 2026 results, with sales rising to US$1,055.7 million and net income to US$96.8 million, while six-month sales reached US$2,199.4 million and net income US$217.3 million. Earnings per share from continuing operations improved on both a basic and diluted basis for the quarter and first half, underlining stronger profitability alongside the company’s push into AI-assisted Intelligent Spaces. We’ll now examine how this stronger profitability,...

Earlier this week, Abercrombie & Fitch announced a renewed global collaboration with Sperry, launching a limited-edition apparel and footwear collection inspired by their shared 1930s heritage and coastal Americana style, now available online and in select stores. The tie-up not only revives a historic brand relationship but also reinforces Abercrombie’s push into curated collaborations that can attract new customers at the start of the key spring–summer shopping season. We’ll now explore...

What Byline Bancorp’s new shelf registration could mean for investors Byline Bancorp (BY) has filed an omnibus shelf registration covering common and preferred stock, depositary shares, debt securities, warrants, purchase contracts, and units. This gives the bank board-authorized flexibility to raise capital over time. See our latest analysis for Byline Bancorp. Byline Bancorp’s latest share price of US$33.15 sits against a 30 day share price return of 8.3% and year to date share price return...

In recent days, Sunbelt Rentals Holdings reported total revenue growth, a 2.6% increase in rental revenue, record free cash flow, US$1.90 billion of year-to-date investment in rental fleet, greenfield expansions and ten bolt-on acquisitions, and launched a new US$1.50 billion share buyback program under its Sunbelt 4.0 plan. This combination of increased rental activity, heavy reinvestment and sizable share repurchases highlights management’s confidence in the company’s cash generation and...